Gliclazide Oral: Dosing and Precautions
Gliclazide guidance for second-line type 2 diabetes treatment in patients over 60 years, with slower titration and hypoglycemia precautions.
Also searched as
Source reviewed
source date listed on the source page
Guide category
Oral drugs
Safety boundary
Prescription medicine information for clinician-guided use.
Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.
Therapeutic action
Sulfonylurea antidiabetic.
Indications
- Second-line treatment of type 2 diabetes in patients over 60 years as monotherapy when metformin is not tolerated or contraindicated.
- In combination with metformin when glycaemic control is inadequate with metformin alone.
Forms and strengths
- 80 mg scored tablet.
Dose and duration
Adult:
- Weeks 1 and 2: 40 mg once daily in the morning.
- Increase if necessary in increments of 40 mg every 2 weeks according to blood glucose levels. Weeks 3 and 4: 80 mg once daily in the morning.
- The usual dose is 80 to 160 mg daily, maximum 240 mg daily.
Contra-indications, adverse effects, precautions
- Do not administer in the event of allergy to sulfonamides, type 1 diabetes, juvenile diabetes, ketoacidosis, or severe renal or hepatic impairment.
- May cause hypoglycaemia, gastrointestinal disturbances, weight gain, and rarely allergic reactions.
- Monitor combination with diuretics, ACE inhibitors, NSAIDs, azole antifungals, ciprofloxacin, erythromycin, and co-trimoxazole because hypoglycaemic effect may be enhanced.
- Rifampicin decreases hypoglycaemic effect.
- Corticosteroids, hydrochlorothiazide, salbutamol, and chlorpromazine may increase blood glucose.
- Avoid combination with alcohol because of the risk of hypoglycaemia.
- Pregnancy: avoid. Insulin is the drug of choice for type 2 diabetes in pregnant women.
- Breast-feeding: contraindicated.
Source
MSF Essential drugs practical guidelines (January 2026)
This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.
Rate this guide
Be the first to rate this guide.
